Danone trims Lifeway Foods (Nasdaq: LWAY) stake in $19.50 share sale
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Lifeway Foods, Inc. disclosed that Danone USA Public Benefit Corporation is conducting a secondary underwritten public offering of 3,454,756 shares of Lifeway common stock at $19.50 per share. All shares are being sold by the selling stockholder, so Lifeway will not receive offering proceeds.
Lifeway has agreed to repurchase approximately $5.0 million of these shares at the same price, with the repurchase conditioned on the closing of the offering, which is expected on May 19, 2026 subject to customary conditions. The transaction is being made under an effective Form S-3 shelf registration, with BTIG, LLC acting as sole underwriter and book-running manager.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 1.01, 8.01, 9.01
3 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Secondary shares offered: 3,454,756 shares
Offering price: $19.50 per share
Planned share repurchase: Approximately $5.0 million
+2 more
5 metrics
Secondary shares offered
3,454,756 shares
Common stock sold by Danone USA Public Benefit Corporation
Offering price
$19.50 per share
Public offering price for secondary sale of common stock
Planned share repurchase
Approximately $5.0 million
Lifeway repurchase of shares in the offering at $19.50
Expected closing date
May 19, 2026
Anticipated closing of secondary underwritten offering
Shelf registration reference
Form S-3 No. 333-291148
Registration statement declared effective December 10, 2025
Key Terms
Underwriting Agreement, secondary underwritten public offering, shelf registration statement, prospectus supplement, +1 more
5 terms
Underwriting Agreement financial
"entered into an underwriting agreement (the “Underwriting Agreement”) with BTIG, LLC"
An underwriting agreement is a contract where a company selling new stocks or bonds hires financial firms to buy those securities and resell them to investors. It matters because the agreement sets the offering price, number of securities, fees and which party bears the risk if sales fall short—think of it as a promise that the sale will happen and a roadmap investors can use to understand how the new securities reach the market.
secondary underwritten public offering financial
"announces pricing of Secondary Underwritten Public Offering of Common Stock"
A secondary underwritten public offering is a sale of already-existing shares by current owners (such as founders, early investors, or institutions) to the public, where one or more investment banks agree to buy any unsold shares and resell them to investors. It matters because it suddenly increases the number of shares available, can put downward pressure on the stock price, and signals that major shareholders are cashing out or providing more liquidity for trading.
shelf registration statement regulatory
"The Offering is being made pursuant to a shelf registration statement on Form S-3"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
prospectus supplement regulatory
"A preliminary prospectus supplement and accompanying prospectus relating to and describing the terms"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
forward-looking statements regulatory
"This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
What secondary offering did Lifeway Foods (LWAY) announce on May 14, 2026?
Lifeway Foods reported a secondary underwritten public offering of 3,454,756 common shares at $19.50 per share. All shares are being sold by Danone USA Public Benefit Corporation, not by Lifeway itself.
Will Lifeway Foods (LWAY) receive any cash from this secondary offering?
Lifeway Foods will not receive proceeds from the 3,454,756-share secondary offering. All sale proceeds go to Danone USA Public Benefit Corporation, which is the selling stockholder in this transaction.
When is the Lifeway Foods (LWAY) secondary offering expected to close?
The secondary offering is expected to close on May 19, 2026. Completion is subject to customary closing conditions typical for underwritten public offerings of common stock.
Who is managing the Lifeway Foods (LWAY) secondary stock sale?
BTIG, LLC is acting as the sole underwriter and sole book-running manager. The offering is being conducted under Lifeway’s effective Form S-3 shelf registration statement and a related prospectus supplement.